Ultragenyx Pharmaceutical (RARE) Q3 2018 Earnings

2AugConfirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-2.09
-1.68
-1.28
-0.87

Details

Expected EPS
-2.09
Actual EPS
-1.06
Surprise EPS
1.03
Surprise Percent
+49.28%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.06 per share for Q3 2018.

0 Comments

Share your thoughts